Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Immunol ; 75: 101662, 2022 12.
Article in English | MEDLINE | ID: mdl-35810979

ABSTRACT

OBJECTIVE: The present study investigates the effects and mechanisms of Yikang decoction on embryo implantation in mice. METHODS: Totally, mature female mice were randomly divided into four groups: normal, implantation failure (mifepristone treatment), Yikang decoction treatment (mifepristone and Yikang decoction treatment), and control (mifepristone and physiological saline treatment) groups. The efficacy of Yikang decoction was evaluated by the adhesion of uterine endometrial cells. The expression of leukemia inhibitory factor (LIF) and integrin αvß3 in the endometrium were detected by real-time quantitative PCR and western blot. In addition, mouse endometrial cells were transfected with LIF specific siRNA-1, and the expression of LIF and αvß3 were detected. RESULTS: The number of embryos markedly decreased after mifepristone treatment. The adhesion of endometrial cells in the Yikang decoction treatment group significantly increased, when compared to the control group. The expression of LIF and integrin αvß3 was significantly reduced by mifepristone, but the attenuated expression of LIF and αvß3 was markedly reversed by treatment with Yikang decoction. In addition, after LIF siRNA-1 transfection, the expression of integrin αvß3 significantly decreased (P < 0.01). The correlation analysis revealed a significant positive correlation between LIF and αvß3 protein expression. CONCLUSION: Yikang decoction can regulate the expression of αvß3 and increase cell adhesion by upregulating the expression of LIF, thereby improving embryo implantation in mice. These data suggest that Yikang decoction may have therapeutic effect in treating infertility.


Subject(s)
Integrin alphaVbeta3 , Mifepristone , Female , Mice , Animals , Leukemia Inhibitory Factor/genetics , Leukemia Inhibitory Factor/metabolism , Leukemia Inhibitory Factor/pharmacology , Integrin alphaVbeta3/genetics , Integrin alphaVbeta3/metabolism , Up-Regulation , Mifepristone/pharmacology , RNA, Small Interfering/genetics , Embryo Implantation/physiology
2.
Biochem Biophys Res Commun ; 534: 780-786, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33162031

ABSTRACT

Ovarian tissue cryopreservation and transplantation (OCT) has been sufficiently proven effective and feasible to preserve fertility for women especially for prepubertal girls suffering from cancer with radiotherapy and chemotherapy. However, grafts' survival, significant follicle loss and a delay of revascularization during OCT still need to be resolved no matter what kind of cryopreserved method being used. Different from previous reports about additives treatment on recipient after ovarian transplantation, we here report a new vitrification protocol with pretreatment of rapamycin, an inhibitor of the mTOR signaling pathway. The rapamycin treatment has been shown to inhibit the activation of mTOR signaling pathway in fresh thawed ovaries or in ovaries shortly grafted in the recipient mice. Further study revealed increased percentage of primordial follicles and reduced apoptosis after 5 days of transplantation. Long-term follow up of ovarian development demonstrated the increase of ovarian survival rates in rapamycin treated ovaries after 2 weeks of transplantation. Although follicular development showed a slight delay with more secondary and early antral follicles found in rapamycin treated ovaries, follicular development was not blocked as manifested by the ovarian morphology after 5 weeks of transplantation. Taken together, the pretreatment of rapamycin before vitrification is a good method for clinical application with its effectiveness on preserving follicle reserve and promoting ovarian survival during the process of OCT.


Subject(s)
Cryopreservation/methods , Organ Preservation/methods , Ovary/drug effects , Ovary/transplantation , Sirolimus/pharmacology , Animals , Apoptosis/drug effects , Cryoprotective Agents/pharmacology , Female , Mice, Inbred ICR , Organ Transplantation/methods , Ovarian Follicle/drug effects , Ovarian Follicle/pathology , Ovary/cytology , TOR Serine-Threonine Kinases/metabolism
3.
Biosci Rep ; 39(7)2019 07 31.
Article in English | MEDLINE | ID: mdl-31123170

ABSTRACT

Background: Endometrial carcinoma (EC) still threatens the health of women. Thus, to explore how long intergenic non-protein coding RNA 01220 regulates the development of EC.Methods: Whole genome expression profile data of EC and paracancerous tissues in TCGA database were downloaded. LINC01220 expression in EC and paracancerous tissues of patients in our hospital were detected by qRT-PCR. Furthermore, the relationship between LINC01220 expression and clinicopathological features of EC patients was analyzed. After transfection with sh-LINC01220 and pcDNA-MAPK11 (mitogen-activated protein kinase) in EC cells, proliferative, colony formation abilities and apoptosis were determined by cell counting kit-8 (CCK-8), colony formation assay and flow cytometry, respectively. Western blot was conducted to determine the regulatory role of LINC01220 on MAPK11.Results: TCGA data showed that LINC01220 expression is markedly higher in EC tissues than that of paracancerous tissues, which was consistent without detection in EC patients of our hospital. LINC01220 expression was positively correlated to pathological grade and International Federation of Gynecology and Obstetrics (FIGO) stage of EC patients. After knockdown of LINC01220 in EC cells, proliferative and colony formation abilities decreased, whereas apoptotic rate increased. Cor function analysis revealed the positive correlation between LINC01220 and MAPK11 in EC. MAPK11 expression was regulated by LINC01220 in EC cells. Overexpression of MAPK11 can reverse the tumor suppressing effect of LINC01220 on EC.Conclusions: LINC01220 promotes EC development by stimulating proliferation and inhibiting apoptosis of EC cells through up-regulating MAPK11.


Subject(s)
Cell Proliferation/genetics , Endometrial Neoplasms/genetics , Mitogen-Activated Protein Kinase 11/genetics , RNA, Long Noncoding/genetics , Apoptosis/genetics , Cell Line, Tumor , Endometrial Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic/genetics , Gene Knockdown Techniques , Genes, Tumor Suppressor , Humans , Transfection
4.
Acta Inform Med ; 27(5): 318-3326, 2019 Dec.
Article in English | MEDLINE | ID: mdl-32210499

ABSTRACT

INTRODUCTION: The American College of Obstetricians and Gynecologists (ACOG) defines postpartum hemorrhage (PPH) as a blood loss of >500mL following vaginal delivery or >1000mL following cesarean section. PPH is widely recognized as a common cause of maternal death. However, there is currently no effective method to predict its risk of occurrence. AIM: To develop a fuzzy expert system to predict the risk of developing PPH and to evaluate its performance in the clinical setting. METHODS: This system was developed using MATLAB software. Mamdani inference was used to simulate reasoning of experts in the field. To evaluate the performance of the system, a dataset of 1705 patients admitted at the Labor and Delivery ward of The Second Affiliated Hospital of Nanjing Medical University from 2017-10 to 2018-04, was considered. RESULTS: The Negative Predictive value (NPV), Positive Predictive value PPV), Specificity and Sensitivity were calculated and were 99.72%, 18.50%, 87.48% and 92.16% respectively. CONCLUSIONS: Our findings suggest that the fuzzy expert system can be used to predict PPH in clinical settings and thus decrease maternal mortality rate due to hemorrhage.

SELECTION OF CITATIONS
SEARCH DETAIL
...